27 November, 2022 Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination. DOI: 10.1007/s00392-022-02129-5
13 October, 2022 Age-stratified infection fatality rate of COVID-19 in the non-elderly informed from pre-vaccination national seroprevalence studies. doi: https://doi.org/10.1101/2022.10.11.22280963
26 September, 2022 Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine – Part 1. Aseem Malhotra. Journal of Insulin Resistance | Vol 5, No 1 | a71 | DOI: https://doi.org/10.4102/jir.v5i1.71 |
Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine – Part 2. Aseem Malhotra. Journal of Insulin Resistance | Vol 5, No 1 | a72 | DOI: https://doi.org/10.4102/jir.v5i1.72
22 September, 2022 Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Joseph Fraiman, Juan Erviti, Mark Jones, Sander Greenland, Patrick Whelan, Robert M.Kaplan, Peter Doshi. Volume 40, Issue 40, 22 September 2022, Pages 5798-5805
14 June, 2022 Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure SCIENCE 14 Jun 2022 Vol 377, Issue 6603 (DOI: 10.1126/science.abq1841)
05 June, 2022 Adverse effects of COVID-19 vaccines and measures to prevent them. Virology Journal volume 19, Article number: 100 (2022)
04 June, 2022 Efficacy and Safety of Vitamin D Supplementation to Prevent COVID-19 in Frontline Healthcare Workers. A Randomized Clinical Trial. Archives of Medical Research. Volume 53, Issue 4, June 2022, Pages 423-430.
25 February, 2022 Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022, 44(3), 1115-1126; https://doi.org/10.3390/cimb44030073
27 January 2022 Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022. Eurosurveillance Volume 27, Issue 4, 27/Jan/2022
15 January 2022 Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching.2022 Jan 15;14(1):e21272. doi: 10.7759/cureus.21272. eCollection 2022 Jan.
17 December 2021 The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory. 2021 Dec 17;24(12):103479. doi: 10.1016/j.isci.2021.103479. Epub 2021 Nov 20.
27 November 2021 Ocular Manifestations after Receiving COVID-19 Vaccine: A Systematic Review. Vaccines 2021, 9(12), 1404; https://doi.org/10.3390/vaccines9121404
20 November 2021 COVID-19: stigmatising the unvaccinated is not justified. Günter Kampf . The Lancet VOLUME 398, ISSUE 10314, P1871, https://doi.org/10.1016/S0140-6736(21)02243-1
11 November 2021 Autoimmunity roots of the thrombotic events after COVID-19 vaccination. https://doi.org/10.1016/j.autrev.2021.102941
08 November 2021 Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning. Circulation. 2021;144:A10712
05 November 2021 Assessment of the National Test Strategy on the Development of the COVID-19
Pandemic in Denmark. Busk, P.K.; Kristiansen, T.B.; Engsig-Karup, A. Epidemiologia 2021, 2, 540–552. https://doi.org/ 10.3390/epidemiologia2040037
27 October, 2021 Waning Immunity after the BNT162b2 Vaccine in Israel. Yair Goldberg, Ph.D., Micha Mandel, Ph.D., Yinon M. Bar-On, M.Sc., Omri Bodenheimer, M.Sc., Laurence Freedman, Ph.D., Eric J. Haas, M.D., Ron Milo, Ph.D., Sharon Alroy-Preis, M.D., Nachman Ash, M.D., and Amit Huppert, Ph.D. October 27, 2021 DOI: 10.1056/NEJMoa2114228
13 October 2021 SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro. Viruses 2021, 13(10), 2056; https://doi.org/10.3390/v13102056
11 October 2021 Subacute thyroiditis after vaccination against SARS-CoV-2 Tidsskr Nor Legeforen 2021doi: 10.4045/tidsskr.21.0554
05 October 2021 Mortality in Norway and Sweden during the COVID-19 pandemic. Scandinavian Journal of Public Health, 2021. Doi.org/10.1177/14034948211047137
5 October 2021 One-year sustained cellular and humoral immunities of COVID-19 convalescents Clinical Infectious Diseases, https://doi.org/10.1093/cid/ciab884
1 October 2021 A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products https://doi.org/10.1016/j.cpcardiol.2021.101011
30 September 2021 Myocarditis after Covid-19 mRNA Vaccination, N Engl J Med 2021; 385:1332-1334 DOI: 10.1056/NEJMc2109975
30 September 2021 Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States. European Journal of Epidemiology (2021) doi:https://doi.org/10.1007/s10654-021-00808-7
25 September 2021 Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. DOI:https://doi.org/10.1016/S0140-6736(21)01608-1
25 September 2021 Cerebral venous sinus thrombosis after vaccination: the UK experience. DOI:https://doi.org/10.1016/S0140-6736(21)01788-8
16 September 2021 Menstrual changes after covid-19 vaccination, BMJ doi:: https://doi.org/10.1136/bmj.n2211.
13 September 2021 Considerations in boosting COVID-19 vaccine immune responses https://doi.org/10.1016/S0140-6736(21)02046-8
30 August 2021 SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis doi: https://doi.org/10.1101/2021.08.30.21262866
25 August 2021 Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections. doi: https://doi.org/10.1101/2021.08.24.21262415
4 August 2021 Myocarditis and Pericarditis After Vaccination for COVID-19 . 2021;326(12):1210-1212. doi:10.1001/jama.2021.13443
July August 2021 COVID-19 vaccine-induced immune thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosis. https://doi.org/10.1016/j.aohep.2021.100356
July August 2021 Covid-19 vaccine- induced thrombosis and thrombocytopenia-a commentary on an important and practical clinical dilemma. https://doi.org/10.1016/j.pcad.2021.05.001
August 2021 Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. ttps://doi.org/10.1016/j.ahjo.2021.100042
20 July 2021 Myocarditis With COVID-19 mRNA Vaccines Circulation. 2021;144:471–484 https://doi.org/10.1161/CIRCULATIONAHA.121.056135
15 July 2021 Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries. BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m2743
14 June 2021 Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study doi: https://doi.org/10.1136/bmj.n1435
June 10, 2021 SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia. DOI: 10.1056/NEJMe2106315
29 April 2021 Fatal cerebral haemorrhage after COVID-19 vaccine. DOI: 10.4045/tidsskr.21.0312
26 February, 2021 Ethics of vaccine refusal . Kowalik M. Ethics of vaccine refusalJournal of Medical Ethics Published Online First: 26 February 2021. doi: 10.1136/medethics-2020-107026
04 January, 2021 Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data. Peter Doshi, The BMJ Opinion January 4, 2021
14 December, 2020 Household Transmission of SARS-CoV-2A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(12):e2031756. doi:10.1001/jamanetworkopen.2020.31756
11 October 2020 Will covid-19 vaccines save lives? Current trials aren’t designed to tell us. BMJ 2020; 371 doi: https://doi.org/10.1136/bmj.m4037
11 October 2020 New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Christian A.Devaux,Jean-MarcRolain, PhilippeColson, DidierRaoult. International Journal of Antimicrobial Agents, Volume 55, Issue 5, May 2020, 105938
